Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
Déclarations de Transparence d’Actionnaires de MDxHealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE3 MARS 2023, 16h30 EDT/22h30 CET IRVINE, CA, et HERSTAL, BELGIQUE – le 3 mars 2023 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (la “Société” ou “mdxhealth“), une société de
MDxHealth Shareholder Transparency Declaration
NEWS RELEASE – REGULATED INFORMATIONFEBRUARY 21, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – 21 February 2023 – MDxHealth SA
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels:
MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
NEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call with Live Q&A, March 8, 2023 at 4:30pm ET/ 22:30 CET IRVINE,
MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
NEWS RELEASEFEBRUARY 22, 2023, 4:30pm ET/ 22:30 CET Company to Host Conference Call with Live Q&A, March 8, 2023 at 4:30pm ET/ 22:30
Déclaration de Transparence d’un Actionnaire de MDxHealth
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE21 FÉVRIER 2023, 16h30 EDT/22h30 CET IRVINE, CA, et HERSTAL, BELGIQUE – le 21 FÉVRIER 2023 – MDxHealth SA (Nasdaq et Euronext Brussels: MDXH) (la “Société” ou “mdxhealth“), une société de
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
NEWS RELEASE – REGULATED INFORMATIONFEBRUARY 15, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 15, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH)
MDxHealth annonce une mise à jour des actions et des droits de vote en circulation et la mise à jour de son calendrier financier
COMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE 15 FÉVRIER 2023, 16h30 EDT/22h30 CET IRVINE, CA, et HERSTAL, BELGIQUE – 15 février 2023 – MDxHealth SA (NASDAQ/Euronext
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
NEWS RELEASE – REGULATED INFORMATION FEBRUARY 15, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 15, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
NEWS RELEASE 13 FEBRUARY 2023, 4:00PM ET / 22:00 CET UnitedHealthcare singles out mdxheath’s GPS test as its only commercially-covered test to risk stratify men
MDxHealth Announces Pricing of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET MDxHealth Announces Pricing of Offering of ADSsin the United States IRVINE, CA,
MDxHealth Announces Pricing of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET IRVINE, CA, and HERSTAL, BELGIUM – February 3, 2023 – MDxHealth
MDxHealth annonce la détermination du prix de l’offre d’ADSs aux États-Unis
COMMUNIQUÉ DE PRESSE INFORMATION PRIVILÉGIÉE ET RÉGLEMENTÉE 3 FÉVRIER 2023, 8h00 EDT/14h00 CET IRVINE, CA, et HERSTAL, BELGIQUE – 3 février 2023 – MDxHealth SA
MDxHealth annonce le lancement d’une offre d’ADSs aux États-Unis
COMMUNIQUÉ DE PRESSE INFORMATION PRIVILÉGIÉE ET RÉGLEMENTÉE 1 FÉVRIER 2023, 16h00 EDT/22h00 CET IRVINE, CA, et HERSTAL, BELGIQUE – 1 février 2023 – MDxHealth SA
MDxHealth Announces Launch of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 1, 2023, 4PM ET/ 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM –February 1, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDxHealth communique des informations financières actualisées et supplémentaires liées à l’acquisition du test GPS
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES 19 JANVIER 2023, 1:00 am ET / 07h00 CET IRVINE, CA, et HERSTAL, BELGIQUE – 20 janvier 2023 –
MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test
NEWS RELEASE –REGULATED INFORMATION 20 JANUARY 2023, 1:00 am ET / 7:00 am CET IRVINE, CA, and HERSTAL, BELGIUM – January 20, 2023 – MDxHealth SA
MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
NEWS RELEASE – INSIDE AND REGULATED INFORMATION 9 JANUARY 2023, 4PM ET / 22:00 CET IRVINE, CA, and HERSTAL, BELGIUM – January 9, 2023 –
MDxHealth dépose une déclaration d’enregistrement aux États-Unis sous la forme d’un formulaire F-3
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES 19 décembre 2022, 16h00 EDT/22h00 CET IRVINE, CA, et HERSTAL, BELGIQUE – 19 décembre 2022 – MDxHealth SA (NASDAQ/Euronext : MDXH),
